Ipamorelin Bloodwork Guide: What to Track and Why

Ipamorelin is the first truly selective growth hormone secretagogue — it triggers GH release from the pituitary without touching cortisol, ACTH, or prolactin. That selectivity is what makes it interesting, and it's also what makes bloodwork straightforward: you're primarily tracking the GH/IGF-1 axis and metabolic markers that respond to elevated growth hormone.

Without labs, you're guessing based on sleep quality and how your skin looks. With labs, you know.

The Testing Timeline

Baseline (before starting): Run all the tests below that match your goals, 1-2 weeks before your first dose. IGF-1 is the anchor — everything gets compared to this number.

Mid-protocol check (week 4-6): Retest IGF-1, fasting insulin, and fasting glucose. This is where you'll confirm GH axis activation and check for insulin sensitivity changes.

Post-protocol (2-4 weeks after finishing): Retest everything you ran at baseline. This tells you what stuck and what bounced back.

What "full panel" means in this guide: IGF-1, fasting insulin, fasting glucose, HbA1c, CBC, CMP, lipid panel, and cortisol as a minimum. Add serum GH if you want a snapshot (drawn 30-60 minutes post-injection for peak), though IGF-1 is more reliable for tracking trends.

Tier 1: Growth Hormone Axis

These are the biomarkers most directly relevant to Ipamorelin's mechanism of action — stimulating pulsatile growth hormone release from the pituitary gland.

Insulin-Like Growth Factor 1 (IGF-1)

What it measures: The downstream mediator of growth hormone. When GH hits the liver, it stimulates IGF-1 production. IGF-1 has a longer half-life than GH itself, making it a stable, reliable marker of overall GH activity.

Why it matters for Ipamorelin: This is your primary objective measure. If Ipamorelin is working — if the pituitary is actually releasing more GH in response — IGF-1 will rise over weeks. A meaningful increase (20-40% above baseline) confirms the protocol is active.

Testing note: Draw IGF-1 fasted, in the morning. It doesn't fluctuate as wildly as GH, but consistency in timing improves comparability across tests.

Serum Growth Hormone (GH)

What it measures: Direct circulating growth hormone at the moment of the blood draw.

Why it matters: A stimulated GH test (drawn 30-60 minutes after Ipamorelin injection) can confirm acute pituitary response. However, GH is released in pulses and has a half-life of about 20 minutes, so a random draw is nearly useless.

Practical advice: IGF-1 is more informative for protocol tracking. Use a stimulated GH test only if you want to confirm pituitary responsiveness early on. It adds cost and complexity that most people don't need.

Tier 2: Metabolic Markers

Growth hormone directly affects glucose and insulin metabolism. Elevated GH can reduce insulin sensitivity — this is a well-documented effect, not a side effect unique to Ipamorelin. Monitoring metabolic markers ensures the GH boost isn't creating downstream metabolic issues.

Fasting Insulin

What it measures: How much insulin your pancreas produces in a fasted state. Higher numbers suggest insulin resistance — your cells aren't responding well to insulin, so the pancreas makes more.

Why it matters for Ipamorelin: GH is a counter-regulatory hormone to insulin. Increased GH can temporarily reduce insulin sensitivity. Tracking fasting insulin catches this early, before glucose levels actually change.

High-performance target: Below 5 uIU/mL. The conventional "normal" range goes up to 25, which is already deep into metabolic dysfunction territory.

Fasting Glucose

What it measures: Blood sugar after an overnight fast. The simplest metabolic snapshot.

Why it matters: If Ipamorelin-driven GH increase is pushing insulin resistance, fasting glucose will eventually rise. This is a lagging indicator — fasting insulin will flag the issue first.

Hemoglobin A1c (HbA1c)

What it measures: Average blood sugar over the past 2-3 months. The long-term metabolic scorecard.

Why it matters: HbA1c won't respond to a few weeks of slightly elevated glucose. But if you're running Ipamorelin protocols over months, HbA1c tells you whether cumulative metabolic impact is significant. It's the "big picture" check.

Tier 3: Body Composition and Lipids

Growth hormone influences fat metabolism, lean mass, and lipid profiles. These markers track the downstream body composition effects that many people use Ipamorelin for.

Lipid Panel

What to track: Total cholesterol, LDL, HDL, and triglycerides. Growth hormone improves lipid profiles in many studies — particularly by reducing visceral fat and improving HDL.

Other lipid targets for high performance: HDL above 60 mg/dL, total cholesterol/HDL ratio below 3.5.

Body Composition (DEXA)

What it measures: Lean mass, fat mass, bone density, and visceral fat — all in one scan.

Why it matters: DEXA isn't a blood test, but it's the gold standard for objectively measuring the body composition changes Ipamorelin is most commonly used for. A baseline and post-protocol DEXA gives you hard numbers on fat loss and lean mass gain that no blood test can provide.

How to get one: Many imaging centers, sports medicine clinics, and DexaFit locations offer DEXA scans for $75-150.

Tier 4: Safety Panel

These ensure Ipamorelin isn't causing unintended problems. Ipamorelin has one major safety advantage: it does not elevate cortisol or ACTH. Including cortisol in your panel actually confirms this selectivity.

Complete Blood Count (CBC)

Checks red blood cells, white blood cells, and platelets. Standard baseline safety check. No specific concerns with Ipamorelin, but always included for completeness.

Comprehensive Metabolic Panel (CMP)

Covers liver enzymes (ALT, AST), kidney function (BUN, creatinine), electrolytes, and protein levels.

Standard lab ranges go up to 40 U/L for ALT, but optimal is below 25.

Cortisol (Morning)

What it measures: Your primary stress hormone, at its daily peak.

Why it matters for Ipamorelin specifically: Unlike other growth hormone secretagogues (GHRP-6, GHRP-2, hexarelin), Ipamorelin does not stimulate cortisol or ACTH release — even at doses over 200-fold higher than the GH-releasing dose. Tracking cortisol confirms this selectivity in your own body. If cortisol rises during an Ipamorelin protocol, the cause is likely external stress, not the peptide.

How to Order Labs

You don't necessarily need a doctor's visit for every test:

• Direct-to-consumer labs: HealthLabs.com lets you order bloodwork without a prescription or insurance. Order online, walk into any of 4,500+ LabCorp or Quest draw sites, and get results in 1-2 business days.
• Your primary care doctor: If you have a good relationship with your doctor, ask them to add these to your regular bloodwork. IGF-1, fasting insulin, and lipid panels are commonly ordered.
• DEXA scans: Separate from bloodwork. Available at imaging centers, DexaFit locations, and some sports medicine clinics.

Budget-conscious approach: If you can only afford a few tests, prioritize in this order:

1. IGF-1 ($30-50) — the single most important marker for Ipamorelin
2. Fasting insulin + fasting glucose ($20-40 together) — metabolic safety
3. CBC + CMP ($20-40 bundled) — general safety

Putting It All Together: Sample Protocol

Week -1 (Baseline): Run IGF-1, fasting insulin, fasting glucose, HbA1c, CBC, CMP, lipid panel, and morning cortisol. Optional: DEXA scan. This is your "before" snapshot.

Week 1-4 (Ipamorelin protocol): Focus on subjective tracking — sleep quality, recovery speed, body composition changes, energy levels. Journal it.

Week 4-5 (Mid-protocol): Retest IGF-1, fasting insulin, and fasting glucose. If IGF-1 rose 20%+ and fasting insulin is still below 8, the protocol is working without metabolic cost. If fasting insulin crept up, consider adjusting dose or timing.

Week 8-12 (Post-protocol): Retest everything you ran at baseline. Optional: follow-up DEXA scan. Compare each marker. Document what changed and by how much.

What to do with results: If IGF-1 increased meaningfully, cortisol stayed flat, and metabolic markers held steady, Ipamorelin is doing exactly what it should. If fasting insulin rose significantly, discuss with a healthcare provider — you may need to adjust protocol or add insulin-sensitizing strategies.

Related Reading

• Ipamorelin Dosing Guide — protocols, timing, and cycles

• Ipamorelin Reconstitution Guide — step-by-step mixing and dilution charts

• CJC-1295 Bloodwork Guide — often paired with Ipamorelin

• BPC-157 Bloodwork Guide — healing peptide biomarker profile

• GHK-Cu Bloodwork Guide — copper peptide tissue repair tracking

• BPC-157 Dosing Guide — commonly stacked healing peptide

References

1. Raun, K., et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552-561. PubMed:9849822
2. Andersen, N.B., et al. (2001). The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth Hormone & IGF Research, 11(5), 266-272. PubMed:11735244
3. Teichman, S.L., et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805. PubMed:16352683

---

This guide is for educational and informational purposes only. It is not medical advice. Ipamorelin is sold as a research compound and is not FDA-approved for human use. The biomarker ranges described here reflect optimization targets used in functional and sports medicine — they are not diagnostic criteria. Lab results should be interpreted by a qualified healthcare provider in the context of your full medical history. The Peptide Catalog is not responsible for medical decisions made based on information presented here. HealthLabs.com links are affiliate links — we may earn a commission at no additional cost to you.